Modulation of glucagon receptor expression
US7919476B2 · kind B2 · utility
2Cited by
21References
33Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 5, 2007 |
| Grant date | Apr 5, 2011 |
| Priority date | — |
| Expiry date | Apr 5, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/346
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds, compositions and methods are provided for modulating the expression of glucagon receptor. The compositions comprise oligonucleotides, targeted to nucleic acid encoding glucagon receptor. Methods of using these compounds for modulation of glucagon receptor expression and for diagnosis and treatment of disease associated with expression of glucagon receptor are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.